This review covers the stable gastric pentadecapeptide BPC 157 and its reported effects in the central nervous system, including work on the gut-brain and brain-gut axis. It describes rat studies in stroke, catalepsy and related models where the peptide was administered and outcomes such as memory, locomotion and coordination were assessed. It is the reference Annular cites for BPC-157 oral stability in its practitioner materials. This is review and animal evidence and does not establish efficacy or safety in human populations.
For your business
Animal and review data suggest oral BPC-157 retains stability; no human efficacy data yet to guide clinical decisions.